Analysts expect Galmed Pharmaceuticals Ltd. to report revenue of 0.00 for Q4 23, against a range of 0.00 to 0.00. The most recent reported quarter, Q4 24, came in at 1.64 M.
| Metric | Q4 23 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 1.64 M | - | - | - | - | - | - | - | |||||||||||||||
| High Estimate | 0.00 | - | 1.71 M | 1.67 M | 1.51 M | 1.34 M | 0.00 | 0.00 | 160,942.73 | |||||||||||||||
| Low Estimate | 0.00 | - | 1.47 M | 1.38 M | 1.40 M | 1.18 M | 0.00 | 0.00 | 147,730.59 | |||||||||||||||
| Consensus Estimate | 0.00 | - | 1.59 M | 1.53 M | 1.45 M | 1.26 M | 0.00 | 0.00 | 154,336.66 |
Analysts expect Galmed Pharmaceuticals Ltd. to report earnings per share of -32.45 for Q4 23, against a range of -33.55 to -31.35. The most recent reported quarter, Q2 26, came in at -5.05, a 73.6% miss against the -2.91 consensus.
| Metric | Q4 23 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | -15.52 | -4.96 | -5.04 | -2.64 | -6.40 | -3.54 | -5.05 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -31.35 | - | -6.19 | -5.83 | -4.10 | -3.55 | -2.74 | -2.63 | -2.75 | -2.94 | 0.45 | -0.69 | -1.17 | -0.64 | 1.38 | |||||||||||
| Low Estimate | -33.55 | - | -7.15 | -6.85 | -5.00 | -4.21 | -2.92 | -3.19 | -3.11 | -3.58 | 0.37 | -0.75 | -1.25 | -0.74 | 1.18 | |||||||||||
| Consensus Estimate | -32.45 | - | -6.67 | -6.34 | -4.55 | -3.88 | -2.83 | -2.91 | -2.93 | -3.26 | 0.41 | -0.72 | -1.21 | -0.69 | 1.28 |
Pull Wall Street consensus for Galmed Pharmaceuticals Ltd. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=EOCN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "EOCN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=EOCN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();